Reuters logo
BRIEF-Cytori Therapeutics says ADRESU incontinence trial hits 50 pct enrollment milestone
December 14, 2016 / 3:36 PM / 9 months ago

BRIEF-Cytori Therapeutics says ADRESU incontinence trial hits 50 pct enrollment milestone

Dec 14 (Reuters) - Cytori Therapeutics Inc :

* Cytori pivotal ADRESU incontinence trial hits 50 pct enrollment milestone

* thus far ADRESU therapy has been well-tolerated by study patients, and we currently anticipate full enrollment in mid-2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below